GSK inaugurates development centre in India

GlaxoSmithKline Pharmaceuticals Limited (GSK) yesterday launched its Technical Development Centre in India. This is GSK's new state of art Technical Development Centre in India. It is intended to cater to the international market for pharmaceutical evaluation by utilizing the expertise of highly skilled Indian Scientists and Engineers, with the latest computerized facilities, conforming to international standards.

The Centre was inaugurated by Jean-Paul Reynaud, SVP, Regional Pharma Supply in the presence of V Thyagarajan, SVP & Area director, Asia Pacific Region, Kay-Yong Tan, VP, India and China sourcing supply and Dr. Ashoke Banerjee, Executive Director, GSK India.

The Centre will develop knowledge in the form of process and product understanding by utilizing Design of Experiments, chemometrics and other lean sigma tools. The new center will support the development of solid, liquid and semisolid dosage forms alongwith analytical and packaging enhancements. This center will cater to the needs of global GSK manufacturing units in order to provide better service to the ultimate customer by improving the quality of product & ensuring security of supply.

Speaking on the occasion of the inauguration, Jean"�Paul Reynaud recognized Indian talent and competencies and said, "At the end of the day what is going to make the difference is people." Talking about the new facility and the way forward, he added, "The purpose for this facility is to serve our customers".

About GlaxoSmithKline:

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer. GSK has two manufacturing sites in India, API manufacturing at Thane and formulation dosage at Nashik.